======= HIST1H1B ======= == Gene Information == * **Official Symbol**: H1-5 * **Official Name**: H1.5 linker histone, cluster member * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3009|3009]] * **UniProt**: [[https://www.uniprot.org/uniprot/P16401|P16401]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HIST1H1B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HIST1H1B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142711|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |Linker histone| |establishment of protein localization to chromatin| |positive regulation of histone H3-K9 methylation| |establishment of protein localization to chromosome| |nucleosome positioning| |negative regulation of chromatin silencing| |nuclear heterochromatin| |regulation of histone H3-K9 methylation| |protein localization to chromatin| |nuclear euchromatin| |negative regulation of gene silencing| |regulation of chromatin silencing| |positive regulation of histone methylation| |chromosome condensation| |nucleosomal DNA binding| |negative regulation of DNA recombination| |negative regulation of chromatin organization| |protein localization to chromosome| |positive regulation of gene expression, epigenetic| |regulation of histone methylation| |nucleosome| |chromatin DNA binding| |positive regulation of histone modification| |double-stranded DNA binding| |regulation of DNA recombination| |positive regulation of chromatin organization| |histone deacetylase binding| |nucleosome assembly| |negative regulation of DNA metabolic process| |regulation of gene silencing| |negative regulation of chromosome organization| |chromatin assembly| |regulation of histone modification| |chromatin assembly or disassembly| |nucleosome organization| |positive regulation of cell growth| |positive regulation of chromosome organization| |protein stabilization| |DNA packaging| |regulation of chromatin organization| |protein-DNA complex assembly| |regulation of gene expression, epigenetic| |nuclear chromatin| |protein-DNA complex subunit organization| |positive regulation of growth| |regulation of protein stability| |muscle organ development| |DNA conformation change| |regulation of chromosome organization| |regulation of DNA metabolic process| |negative regulation of organelle organization| |regulation of cell growth| |establishment of protein localization to organelle| |muscle structure development| |positive regulation of organelle organization| |regulation of growth| |chromatin organization| |negative regulation of cellular component organization| |protein localization to organelle| |cellular protein-containing complex assembly| |negative regulation of transcription by RNA polymerase II| |chromosome organization| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |protein-containing complex assembly| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-2.41| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-2.32| |[[:results:exp453|B02 10μM R08 exp453]]|-2.1| |[[:results:exp134|MS023 2μM R03 exp134]]|-2.04| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-2.03| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.02| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-2.01| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-1.95| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.76| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.77| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|2.02| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.13| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|2.15| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.37| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.43| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.6| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|2.91| ^Gene^Correlation^ |[[:human genes:c:cramp1l|CRAMP1L]]|0.502| |[[:human genes:h:hist1h1e|HIST1H1E]]|0.46| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5097 * **Expression level (log2 read counts)**: 0.13 {{:chemogenomics:nalm6 dist.png?nolink |}}